Home›Search›Drug Design, Development and Therapy

Drug Design, Development and Therapy

Dove Medical Press Ltd · New Zealand · Est. 1987

ISSN1177-8881eISSN1177-8881

SJR Q1✓ WOS SCIE✓ Scopus / SJR✓ DOAJ✓ Open Access

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 25% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

1.309

H-Indexi

128

SNIPi

1.352

Total Worksi

5,488

Total Citationsi

136,700

2yr Mean Citednessi

3.68

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal.

General Information

Country / RegionNew Zealand

Primary LanguageEnglish

1st Year Published1987

Annual Volume~ 491 articles / year

StatusActive (last: 2026)

Total Publications5,488

Publisher OrgDove Medical Press

OA Since2006

Visit Journal Website

Submission Info

Peer ReviewSingle-blind

OA LicenseCC BY, CC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

PMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/11 · 91%

✅

Do you know the journal / publisher?

Dove Medical Press Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1177-8881 / 1177-8881

✅

Indexed in a trusted database?

WoS, Scopus, DOAJ, PubMed

✅

Peer review process documented?

Single-blind

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

364

12k

2019

480

16k

2020

399

12k

2021

315

7.1k

2022

283

2023

427

4.7k

2024

762

3.3k

2025

621

221

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ1

Pharmaceutical ScienceQ1

PharmacologyQ1

Subject Classification

Web of Science Categories

Chemistry, MedicinalPharmacology & Pharmacy

Scopus Categories

PharmacologyDrug DiscoveryPharmaceutical Science

Research Topics (OpenAlex)

Anesthesia and Sedative AgentsAnesthesia and Pain ManagementAdvanced Drug Delivery SystemsNausea and vomiting managementDrug Solubulity and Delivery SystemsTraditional Chinese Medicine AnalysisIntensive Care Unit Cognitive DisordersDiabetes Treatment and ManagementNanoparticle-Based Drug DeliveryAdvancements in Transdermal Drug Delivery

Frequently asked questions about Drug Design, Development and Therapy

Is Drug Design, Development and Therapy a predatory journal?

PubScope has no integrity flags on record for Drug Design, Development and Therapy: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Drug Design, Development and Therapy?

Drug Design, Development and Therapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 3.68.

Is Drug Design, Development and Therapy indexed in Scopus and Web of Science?

Drug Design, Development and Therapy is indexed in Web of Science, Scopus, DOAJ.